Executive Summary
The 15 filings reveal a surge in SPAC activity with multiple IPOs (Plutonian $100M, Quantum Leap $200M), unit separations, and deadline extensions (GP-Act III to Nov 2026, Legato to Aug 2026), signaling robust blank check company fundraising amid M&A appetite. Key M&A/takeover highlights include Broadwind's $19.5M facility sale and pivot to precision manufacturing, 908 Devices' NIRLAB acquisition with raised FY2026 revenue guidance to $67-70M (19-25% growth), Nuveen Churchill funds' $347M asset swap, and Brookfield's $1.2B takeover of Peakstone Realty Trust. Period-over-period trends show revenue growth in operating companies (908 Devices +14% YoY to $13.4M, Ascent +9% YoY to $19.4M) but margin pressures (Ascent -272bps to 14.5%, 908 gross +400bps to 51% offset by wider $12M net loss). Mixed sentiments dominate earnings/divestitures, with SPACs neutral-to-positive and compliance risks emerging. Portfolio-level pattern: 7/15 filings involve SPAC lifecycle events, 5 M&A transactions, indicating heightened US takeover activity but with execution risks like high redemptions and guidance withdrawals.
Tracking the trend? Catch up on the prior US Merger & Acquisition SEC Filings digest from April 29, 2026.
Investment Signals(10)
- Plutonian Acquisition Corp. II↓(BULLISH)▲
Completed $100M IPO + $2.1M private placement at $10/unit, units trading on NYSE, strong liquidity for business combination targeting
- Quantum Leap Acquisition Corp↓(BULLISH)▲
Priced $200M IPO (20M units at $10), targeting AI/quantum/blockchain (ex-China), underwriter option for 3M more units, trading starts May 1
- 908 Devices Inc.↓(BULLISH)▲
Q1 revenue +14% YoY to $13.4M, gross margin +400bps to 51% (adj 57%), recurring rev 30%, raised FY2026 guidance $67-70M (+19-25% over 2025), acquired NIRLAB
Completed $347M asset acquisition from BDC V at NAV, assumed $511M debt, funded via $337M borrowings, board/shareholder approved
Acquired by Brookfield for $1.2B ($21/share cash), 70+ industrial assets integrated into global platform, shares delisted post-close May 6 [BULLISH for Brookfield]
Q1 sales +9% YoY to $19.4M, $3.9M share repurchases (3.2% of shares at $12.92 avg), strong liquidity $47.8M cash/no debt [BULLISH on capital allocation]
Sold Abilene facility for up to $19.5M cash/non-cash, exits wind towers post-Manitowoc sale, pure-play precision mfg with $300M NOLs for growth redeployment [BULLISH strategic pivot]
Extended business combination deadline to Aug 8 2026 via insider-funded $0.03/share monthly contributions, maintains shareholder protections [BULLISH extension]
$1M subscription for 100k shares at $10 pre-merger with Goodvision AI, supports closing of March 2026 deal [BULLISH funding]
Sold assets to affiliate PCAP for $347M at NAV, unanimous board/shareholder approval, no performance declines [BULLISH disposition]
Risk Flags(8)
- Broadwind, Inc./Guidance Withdrawal↓[HIGH RISK]▼
Withdrew full-year 2026 guidance post-$19.5M Abilene sale (2025 wind rev $56.3M, EBITDA $9.7M), introduces earnings uncertainty
- 908 Devices Inc./Loss Expansion↓[MEDIUM RISK]▼
Q1 net loss widened to $12M from $9.8M YoY, op ex +$3.2M to $19.8M driven by $6.4M contingent consideration jump
- Ascent Industries Co./Margin Compression↓[HIGH RISK]▼
Q1 gross margin -272bps YoY to 14.5%, Adj EBITDA loss deepened to -$1M from -$0.5M, Specialty Chemicals margin -5.9% vs +11%
- ▼
Nasdaq non-compliance notice for min public holders (Rule 5550(a)(3)), 45-day plan due June 22, potential 180-day extension but no compliance guarantee
- GP-Act III Acquisition Corp./Shareholder Opposition↓[MEDIUM RISK]▼
Adjourned meeting to May 12 after Extension/Trust proposals faced opposition (8M against votes), high redemptions risk despite 82% representation
- Calisa Acquisition Corp./Merger Risks↓[MEDIUM RISK]▼
$1M subscription contingent on Goodvision merger close, risks include failure to close, high public redemptions, rep/warranty breaches
- ▼
Unit separation election May 11 requires transfer agent contact, potential liquidity/execution friction for holders
- Eureka Acquisition Corp./Funding↓[LOW RISK]▼
Issued $150k interest-free convertible note to fund operations pre-business combination, repayable from non-trust if no deal
Opportunities(8)
- Plutonian Acquisition Corp. II/IPO Liquidity↓(OPPORTUNITY)◆
Fresh $102.1M proceeds positions for quick business combination, NYSE-listed units/shares/rights offer M&A play entry
- Quantum Leap Acquisition Corp/Sector Focus↓(OPPORTUNITY)◆
$200M dry powder for AI/quantum/blockchain deals (ex-China), oversized IPO vs peers like Plutonian signals conviction
- 908 Devices Inc./Guidance Raise↓(OPPORTUNITY)◆
FY2026 rev guide up to $67-70M post-NIRLAB buy, +14% YoY Q1 rev/margin expansion, cash burn <$1.5M supports growth
- Broadwind, Inc./Proceeds Redeployment↓(OPPORTUNITY)◆
$19.5M from sale + $300M NOLs for precision mfg growth, post-wind exit improves focus vs diversified peers
- Ascent Industries Co./Buybacks↓(OPPORTUNITY)◆
Repurchased 3.2% shares at $12.92 avg with $47.8M cash/no debt, undervalued liquidity play despite Q1 EBITDA loss
- Peakstone Realty Trust/Takeover Premium↓(OPPORTUNITY)◆
$1.2B Brookfield deal at $21/share delists public co, opportunity in similar industrial REITs pre-bid
- Nuveen Churchill Funds/Asset Swap(OPPORTUNITY)◆
$347M NAV transfer scales PCAP platform, debt-funded but Rule 17a-8 compliant, BDC unwind creates closed-end fund alpha
- Legato Merger Corp. III/Extension↓(OPPORTUNITY)◆
Insider-funded extension to Aug 2026 buys time for deal, lower monthly cost vs full redemption
Sector Themes(5)
- SPAC Lifecycle Surge◆
9/15 filings (Plutonian, Quantum, Future Vision, Blue Water, GP-Act III, Calisa, Eureka, Legato, Evolution) show IPOs ($300M+ total), separations, extensions, funding – implies rising M&A deal flow but redemption/delisting risks in 40% of cases
- M&A Completions Dominant◆
5/15 transactions closed (Broadwind sale $19.5M, 908 NIRLAB, Nuveen $347M swap, Peakstone $1.2B takeover) at/above NAV, positive sentiment avg, vs 1 pending (Calisa) – sector consolidation accelerating
- Mixed Industrial Earnings◆
3/15 ops reports (Broadwind pivot, 908 +14% rev/+400bps margin but wider loss, Ascent +9% rev/-272bps margin) highlight volume/price gains offset by costs/expenses, 2/3 withdrew/raised guidance
- Capital Allocation Shift◆
Repurchases (Ascent 3.2% shares), NOL leverage (Broadwind $300M), insider funding (Legato $0.03/share monthly) prioritize returns/reinvestment over dividends, strong balance sheets (Ascent $47.8M cash/no debt)
- China Exposure Avoidance◆
Quantum Leap excludes China/HK/Taiwan/Macau targets, Future Vision Shanghai-based faces Nasdaq delisting – geopolitical risk premium in SPACs
Watch List(7)
Monitor guidance replacement post-sale, wind exit impacts on May 12 call
Q1 details, FY guide validation, cash burn trends on May 6 8:30am ET call (ongoing)
Extension/Trust votes, redemption reversals by May 12 9am ET, high opposition risk
Plan submission by June 22, delisting path or cure for min holders rule
$1M funding tied to Goodvision AI deal completion, watch redemptions/conditions
Brookfield integration of 70 industrial assets, similar REIT bid speculation
Margin recovery from -272bps Q1 compression, repurchase continuation with $14.2M revolver availability
Filing Analyses(15)
06-05-2026
Plutonian Acquisition Corp II consummated its initial public offering (IPO) on April 29, 2026, selling 10,000,000 units at $10.00 per unit for gross proceeds of $100,000,000. Simultaneously, the company completed a private placement of 210,000 units to Plutonian Capital II LLC at $10.00 per unit, generating $2,100,000 in proceeds. An audited balance sheet reflecting these transactions is included as Exhibit 99.1.
- ·Each unit consists of one Class A ordinary share ($0.0001 par value) and one right entitling holder to 1/4 Class A ordinary share upon initial business combination.
- ·Securities traded on NYSE: PLUNU (units), PLUN (Class A shares), PLUNR (rights).
- ·Event date: April 29, 2026; Filing date: May 6, 2026.
06-05-2026
Quantum Leap Acquisition Corp, a blank check company targeting AI, quantum computing, and blockchain sectors, announced the pricing of its $200 million initial public offering of 20,000,000 units at $10.00 per unit, with trading expected to begin on NYSE under 'QLEPU' on May 1, 2026, and closing on May 4, 2026. Underwriters A.G.P./Alliance Global Partners received a 45-day option to purchase up to 3,000,000 additional units. The IPO includes one Class A ordinary share and one redeemable warrant per unit, exercisable at $11.50 per share.
- ·Units expected to separate trade with ordinary shares under 'QLEP' and warrants under 'QLEPW'.
- ·Excludes pursuit of targets in China, Hong Kong, Taiwan, and Macau.
- ·Registration statement File No. 333-293359 declared effective April 30, 2026.
- ·Leadership team has more than six decades of collective experience in relevant sectors.
06-05-2026
Broadwind announced the sale of its Abilene, Texas facility to IES Infrastructure for up to $19.5 million in cash and non-cash consideration, marking a strategic exit from the wind tower manufacturing market following the prior Manitowoc sale. This pivot positions the company as a pure-play precision manufacturer focused on power generation and critical infrastructure, retaining its PRS business and planning to redeploy proceeds into growth opportunities while leveraging $300 million in NOL carryforwards. However, the company withdrew its full-year 2026 financial guidance due to the transaction, introducing uncertainty, and the Abilene wind operations generated $56.3 million in revenue and $9.7 million in Adjusted EBITDA in 2025 excluding PRS.
- ·Agreement dated April 30, 2026; short-term lease ends September 5, 2026
- ·Earnings conference call scheduled for May 12, 2026
- ·2026 financial guidance originally issued March 11, 2026, now withdrawn
- ·Wind revenue historically concentrated with one large OEM customer
- ·Adjusted EBITDA reconciliation: 2025 Net Income $5,403K + Interest $1,036K + Depreciation $2,875K + Share-based comp $352K = $9,666K
06-05-2026
Future Vision II Acquisition Corp. received a Nasdaq notice on May 5, 2026, stating non-compliance with the minimum public holders requirement under Listing Rule 5550(a)(3) for continued listing on the Nasdaq Capital Market. The notice provides 45 days until June 22, 2026, to submit a compliance plan, with a possible 180-day extension if accepted, but offers no assurance of regaining or maintaining compliance. The Company is evaluating options but faces delisting risk with no immediate impact on trading.
- ·Nasdaq Listing Rule 5550(a)(3) is the specific rule violated.
- ·Principal executive offices: Xiandai Tongxin Building 201 Xin Jinqiao Road, Rm 302, Pudong New District, Shanghai, China.
- ·Registrant telephone: + (86) 136 0300 0540.
- ·Emerging growth company: Yes.
06-05-2026
908 Devices Inc. reported Q1 2026 revenue of $13.4 million, up 14% YoY, driven by mass spec product growth and FTIR mix shift, with GAAP gross margin expanding 400 basis points to 51% (adjusted 57%) and recurring revenue at 30% of total. The company acquired NIRLAB AG to bolster narcotics detection and recurring subscriptions, while raising FY2026 revenue guidance to $67.0-70.0 million (19-25% growth over 2025). However, net loss from continuing operations widened to $12.0 million from $9.8 million YoY, due to $19.8 million operating expenses (up from $16.6 million), including a $6.4 million increase in fair value of contingent consideration.
- ·OEM and funded partnership revenue flat at $0.6 million YoY.
- ·Cash consumption less than $1.5 million in Q1 2026.
- ·Conference call scheduled for May 6, 2026 at 8:30 am ET.
06-05-2026
On May 6, 2026, Blue Water Acquisition Corp. IV announced that, on or about May 11, 2026, holders of its units (BWIV.U) may elect to separately trade the underlying Class A ordinary shares (BWIV) and warrants (BWIV.WS) on the NYSE. Units not separated will continue trading under BWIV.U. Holders must contact the transfer agent, Continental Stock Transfer & Trust Company, to separate units.
- ·Registrant incorporated in Cayman Islands, Commission File Number 001-43204.
- ·Principal executive offices: 15 E. Putnam Avenue Suite 363, Greenwich, CT 06830; Telephone: (203) 489-2110.
- ·Emerging growth company status: Yes.
06-05-2026
GP-Act III Acquisition Corp. adjourned its extraordinary general meeting from May 6, 2026, to May 12, 2026, after shareholders approved the Adjournment Proposal with 21,424,593 votes in favor versus 8,064,137 against and 1,000 abstentions, with 82.06% of 35,937,500 shares represented. The adjournment facilitates further proxy solicitation for the Extension Amendment Proposal and Trust Amendment Proposal to extend the business combination deadline from May 13, 2026, to November 13, 2026, while significant opposition votes highlight shareholder division. The company is also allowing shareholders to reverse prior redemption requests ahead of the adjourned meeting.
- ·Record date for meeting: March 24, 2026
- ·Proxy statement filed with SEC: March 30, 2026
- ·Redemption reversal deadline: 9:00 a.m. ET on May 12, 2026 via spacredemptions@continentalstock.com
- ·Adjourned meeting access: https://www.cstproxy.com/gp-act3/2026 or phone 1-800-450-7155 (US/Canada) / +1-857-999-9155 (international), ID 7686293#
- ·In-person location: Skadden, Arps offices in São Paulo, Brazil
06-05-2026
Ascent Industries Co. reported Q1 2026 net sales from continuing operations of $19.4 million, up 9.0% YoY from $17.8 million, driven by higher volumes and selling prices. However, gross profit declined 8.3% to $2.8 million with margin contracting 272bps to 14.5%, and Adjusted EBITDA worsened to a $1.0 million loss from $0.5 million due to manufacturing variances and onboarding inefficiencies. Net loss from continuing operations improved slightly to $2.0 million ($0.21 per share) from $2.2 million ($0.22 per share), with strong liquidity at $47.8 million cash, no revolver debt, and $3.9 million used for share repurchases representing 3.2% of outstanding shares.
- ·Revolver availability of $14.2 million as of March 31, 2026 with no debt outstanding.
- ·Share repurchases at average cost of $12.92 per share, representing 3.2% of outstanding shares.
- ·Specialty Chemicals Adjusted EBITDA margin -5.9% in Q1 2026 vs 11.0% in Q1 2025.
- ·Cash decreased from $57.6 million at Dec 31, 2025 to $47.8 million at March 31, 2026.
06-05-2026
Calisa Acquisition Corp entered into a Subscription Agreement on April 30, 2026, with an accredited investor to issue 100,000 Class A ordinary shares at $10.00 per share for $1 million in gross proceeds, immediately prior to and contingent upon the consummation of its previously announced merger with Goodvision AI Inc. This supports the ongoing business combination initially agreed on March 6, 2026, but closing is subject to conditions including merger completion and representations/warranties. The filing highlights significant risks such as potential failure to close the merger, high redemptions by public shareholders, and other uncertainties that could prevent realization of benefits.
- ·Subscription Agreement closing conditioned on substantially concurrent Merger consummation and accuracy of Goodvision's representations/warranties.
- ·Shares offered under Section 4(a)(2) exemption, Regulation S and/or Regulation D.
- ·Accompanying Registration Rights Agreement provides certain registration rights to the Investor.
06-05-2026
On May 1, 2026, Nuveen Churchill Private Capital Income Fund completed its acquisition of substantially all assets of Nuveen Churchill BDC V for a purchase price of $346,954,197, equal to BDC V's net asset value as of April 29, 2026. The Fund assumed $511,000,000 of BDC V’s indebtedness under its credit facility and funded the purchase price with $337,313,101 of borrowings under credit facilities with Bank of America and the Bank of Nova Scotia, with $9,641,096 settled on a net basis. The transaction was approved by both boards, including independent trustees, and BDC V shareholders on April 30, 2026.
- ·Purchase and Sale Agreement dated April 1, 2026
- ·Transaction approved by Fund Board and BDC V Board, including all non-interested trustees, consistent with Rule 17a-8 under 1940 Act
- ·BDC V shareholders approved transaction at virtual meeting on April 30, 2026
- ·Fund and BDC V are affiliated BDCs externally managed by related entities controlled by Nuveen, LLC
- ·Financial statements and supplemental disclosure under Rule 6-11 of Regulation S-X to be filed as amendment to this 8-K
06-05-2026
Nuveen Churchill BDC V completed the sale of substantially all its assets to affiliated Nuveen Churchill Private Capital Income Fund (PCAP) on May 1, 2026, for a purchase price of $346,954,197 equal to the Fund's net asset value as of April 29, 2026, with PCAP assuming $511,000,000 of the Fund's indebtedness. The transaction, approved unanimously by the Fund Board, PCAP Board, and all 13,479,560 shareholders at a special meeting on April 30, 2026, was funded by PCAP with $337,313,101 in borrowings from Bank of America and Bank of Nova Scotia, with $9,641,096 settled on a net basis. No performance declines or flat metrics were reported in this asset disposition filing.
- ·Purchase Agreement dated April 1, 2026; transaction effective May 1, 2026 following shareholder meeting on April 30, 2026
- ·Boards of both Fund and PCAP approved transaction consistent with Rule 17a-8 under 1940 Act, including all independent trustees
- ·Fund shareholders also approved withdrawal of BDC election under 1940 Act
- ·Fund and PCAP are externally managed affiliates controlled by Nuveen, LLC
06-05-2026
On May 5, 2026, Ashley Zumwalt-Forbes resigned as Chief Operating Officer and Director of Evolution Global Acquisition Corp, effective immediately, with no disagreement on any matter relating to the Company’s operations, policies, or practices. On May 6, 2026, the Company appointed Michael Bloom as an independent director, effective immediately, to serve on the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee. Mr. Bloom, founder and Managing Director of Present Capital, has prior experience at Traba, Inc., Aperture Investors, and LHC Capital.
- ·Michael Bloom is age 33 and holds a Bachelor of Commerce from the University of Sydney.
- ·The Board qualified Mr. Bloom based on his capital-allocation experience, operating background, private business acquisition engagement, and focus on AI and process automation.
06-05-2026
Eureka Acquisition Corp issued an interest-free promissory note for US$150,000 to Marine Thinking Inc. on May 4, 2026, to fund operations until consummation of a business combination or maturity. The note is convertible into private units at $10.00 per unit and includes standard events of default and repayment from non-trust funds if no business combination occurs. No performance metrics or period comparisons are provided.
- ·Note dated May 4, 2026; filing date May 6, 2026.
- ·Conversion notice required at least two business days prior to business combination closing.
- ·No interest unless overdue; payable only from non-trust account funds if no business combination.
- ·Governed by New York law; Prospectus File No. 333-277780.
06-05-2026
Brookfield Asset Management completed its acquisition of Peakstone Realty Trust on May 6, 2026, in an all-cash transaction valued at approximately $1.2 billion, with Peakstone shareholders receiving $21.00 per share. Peakstone's shares ceased trading on the NYSE, and the company became privately held, with its portfolio of over 70 industrial assets, including industrial outdoor storage and traditional industrial properties, integrated into Brookfield’s global logistics platform. The deal strengthens Brookfield’s industrial real estate exposure, though it results in Peakstone's delisting and privatization.
- ·Advisors to Brookfield: Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC (financial); Gibson, Dunn & Crutcher LLP, Thompson Hine LLP (legal).
- ·Advisors to Peakstone: BofA Securities, Inc. (exclusive financial); Latham & Watkins LLP, O’Melveny & Myers LLP, Hogan Lovells US LLP (legal).
06-05-2026
Legato Merger Corp. III adopted special resolutions to amend its Amended and Restated Memorandum and Articles of Association, extending the Business Combination deadline from May 8, 2026, to up to August 8, 2026, through monthly extensions funded by $0.03 per Public Share contributions deposited into the Trust Account by Insiders, including Einride AB or designees. The amendments also update redemption rights for Public Shares in case of amendments or failure to complete the Business Combination by the Extended Date, maintaining protections for public shareholders. No financial declines or flat metrics reported.
- ·Amendments replace Articles 48.7 and 48.8 entirely.
- ·Extensions require Resolution of Directors and contributions for each month used.
- ·Liquidation process triggered if no Business Combination by Extended Date, with redemption at Trust Account value per Public Share.
Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 15 filings
More from: US Merger & Acquisition SEC Filings
🇺🇸 More from United States
View all →April 29, 2026
US Pre-Market SEC Filings Roundup — April 29, 2026
US Pre-Market SEC Filings Roundup
April 29, 2026
US Activist Hedge Fund Institutional SEC 13D 13G — April 29, 2026
US Activist Hedge Fund Institutional SEC 13D 13G
April 29, 2026
Nasdaq 100 Stocks SEC Filings — April 29, 2026
Nasdaq 100 Stocks SEC Filings
April 29, 2026
S&P 500 Technology Sector SEC Filings — April 29, 2026
S&P 500 Technology Sector SEC Filings